US Biologic® to Present at World Vaccine Congress April 20 |

MEMPHIS, Tenn., April 18, 2022 /PRNewswire/ — US Biologic today announced that Dr. Jolieke G. van Oosterwijk, Chief Scientific Officer, will present at World Vaccine Congress Washington 2022 at washington d.c. on Wednesday, April 20, 2022to 3:25 p.m. ET.

Surveillance is not the last step in preventing pandemics that can cost millions of lives and billions of dollars in economic damage.

Dr. van Oosterwijk will speak on the topic “Using Zoonotic Disease Surveillance to Guide Oral Vaccine Design” and present the methods used by US Biological to effectively prevent pandemic disease during early surveillance.

“Surveillance is an essential first step,” says van Oosterwijk, “but it is not the last step in preventing pandemics that can cost millions of lives and billions of dollars in economic damage.” In the presentation, Dr. van Oosterwijk will link effective surveillance, rapid vaccine design, manufacture and application, and the interactions between complementary animal and human vaccination campaigns.

“Seventy-five percent of all emerging infectious diseases start with animals,” says David Sander, executive director of Securing America’s Medicines and Supply (SAMS), of which US Biologic is a member. “US Biologic’s Oral Delivery Platform provides an essential toolkit to protect the health and safety of the United States. How else are we going to prevent the next animal-derived pandemic?”

About US Organics:

US Biological “Provides disease prevention®“. The Company’s proprietary oral delivery platform is changing global disease prevention, enabling safe, effective and cost-effective delivery of vaccines and therapeutics. The Company develops orally delivered animal vaccines against transmitted diseases by ticks, antimicrobial resistant bacteria and African bacteria Swine fever, among others.The company has also partnered with the program of the Division of Research, Innovation and Enterprise (DRIVe) of the Biomedical Advanced Research and Development Authority (BARDA) to develop an orally administered flu vaccine for humans.

Strive. Innovate. Deliver.

View original content to download multimedia: https://www.prnewswire.com/news-releases/us-biologic-to-present-at-world-vaccine-congress-on-april-20-301526996.html

SOURCEUS Biological, Inc.

Comments are closed.